UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Worst-Rank Score Methods-A Nonparametric Approach to Informatively Missing Data

JAMA : the journal of the American Medical Association, 2020-10, Vol.324 (16), p.1670

Lachin, John M

2020

Volltextzugriff (PDF)

How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

Diabetes care, 2018-02, Vol.41 (2), p.356-363

2018

Volltextzugriff (PDF)

Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial

Diabetes (New York, N.Y.), 2014-02, Vol.63 (2), p.739-748

2014

Volltextzugriff (PDF)

Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality

JAMA : the journal of the American Medical Association, 2015-01, Vol.313 (1), p.45

2015

Volltextzugriff (PDF)

Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial

European heart journal, 2018-02, Vol.39 (5), p.363-370

2018

Volltextzugriff (PDF)

Large sample inference for a win ratio analysis of a composite outcome based on prioritized components

Biostatistics (Oxford, England), 2016-01, Vol.17 (1), p.178-187

2016

Volltextzugriff (PDF)

Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study

Diabetes (New York, N.Y.), 2014-01, Vol.63 (1), p.282-290

2014

Volltextzugriff (PDF)

Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

Diabetes care, 2013-08, Vol.36 (8), p.2254-2261

2013

Volltextzugriff (PDF)

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions

Diabetes (New York, N.Y.), 2013-12, Vol.62 (12), p.3976-3986

2013

Volltextzugriff (PDF)

Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study

Diabetes care, 2019-05, Vol.42 (5), p.875-882

2019

Volltextzugriff (PDF)

Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial—Revisited

Diabetes (New York, N.Y.), 2008-04, Vol.57 (4), p.995-1001

2008

Volltextzugriff (PDF)

Evaluating the Role of Epigenetic Histone Modifications in the Metabolic Memory of Type 1 Diabetes

Diabetes (New York, N.Y.), 2014-05, Vol.63 (5), p.1748-1762

2014

Volltextzugriff (PDF)

Applications of the Wei-Lachin multivariate one-sided test for multiple outcomes on possibly different scales

PloS one, 2014-10, Vol.9 (10), p.e108784-e108784

2014

Volltextzugriff (PDF)

Fallacies of last observation carried forward analyses

Clinical trials (London, England), 2016-04, Vol.13 (2), p.161-168

Lachin, John M

2016

Volltextzugriff (PDF)

Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)

Cardiovascular diabetology, 2014-06, Vol.13 (1), p.102-102

2014

Volltextzugriff (PDF)

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

The New England journal of medicine, 2006-12, Vol.355 (23), p.2427-2443

2006

Volltextzugriff (PDF)

A review of methods for futility stopping based on conditional power

Statistics in medicine, 2005-09, Vol.24 (18), p.2747-2764

Lachin, John M.

2005

Volltextzugriff (PDF)

Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®)

Diabetes & vascular disease research, 2015-05, Vol.12 (3), p.164-174

2015

Volltextzugriff (PDF)

Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study

Clinical journal of the American Society of Nephrology, 2016-11, Vol.11 (11), p.1969-1977

2016

Volltextzugriff (PDF)

Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention Program

Diabetes care, 2007-10, Vol.30 (10), p.2453-2457

2007

Volltextzugriff (PDF)

Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study

Diabetes care, 2010-05, Vol.33 (5), p.1090-1096

2010

Volltextzugriff (PDF)

Mediation of the association of smoking and microvascular complications by glycemic control in type 1 diabetes

PloS one, 2019-01, Vol.14 (1), p.e0210367-e0210367

2019

Volltextzugriff (PDF)

Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studies

PloS one, 2021-11, Vol.16 (11), p.e0257154-e0257154

2021

Volltextzugriff (PDF)

Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes

Diabetes care, 2006-09, Vol.29 (9), p.2102-2107

2006

Volltextzugriff (PDF)

Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients

Journal of diabetes investigation, 2022-01, Vol.13 (1), p.125-133

2022

Volltextzugriff (PDF)

1 – 25 von 498

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(394)
Mit Volltextzugriff
(432)

Publikationsform

Sprache

Englisch
(498)

Erscheinungsjahr

n.n

Thema

Science & Technology
(283)
Life Sciences & Biomedicine
(274)
Humans
(269)
Diabetes
(170)
Male
(161)
Female
(157)
Endocrinology & Metabolism
(128)
Adult
(125)
Risk Factors
(111)
Diabetes Mellitus
(98)
Middle Aged
(88)
Biological And Medical Sciences
(83)
Medical Sciences
(81)
Diabetes Mellitus, Type 1 - Complications
(74)
Mathematics
(71)
Research Design
(67)
Adolescent
(66)
Clinical Trials
(61)
Young Adult
(60)
Diabetes. Impaired Glucose Tolerance
(58)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Diabetes Care
(94)
Diabetes
(48)
Statistics In Medicine
(31)
Controlled Clinical Trials
(24)
The New England Journal Of Medicine
(24)
Circulation
(13)
Biometrics
(11)
New England Journal Of Medicine/the new England Journal Of Medicine
(11)
Clinical Trials
(9)
Plos One
(9)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Worst-Rank Score Methods-A Nonparametric Approach to Informatively Missing Data

How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial

Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality

Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial

Large sample inference for a win ratio analysis of a composite outcome based on prioritized components

Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study

Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions

Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study

Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial—Revisited

Evaluating the Role of Epigenetic Histone Modifications in the Metabolic Memory of Type 1 Diabetes

Applications of the Wei-Lachin multivariate one-sided test for multiple outcomes on possibly different scales

Fallacies of last observation carried forward analyses

Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

A review of methods for futility stopping based on conditional power

Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®)

Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study

Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention Program

Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study

Mediation of the association of smoking and microvascular complications by glycemic control in type 1 diabetes

Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studies

Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes

Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients

Suchergebnisse filtern